AKANVSOBIO• 28 Days (Normalized)
AKAN vs OBIO (Akanda Corp. vs Orchestra BioMed Holdings Inc.)
Showing Closing Date Range from Aug, 18 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AKAN Performance $2.68
-44.83%
Akanda Corp.
Normalized Baseline0.00%
OBIO Performance $5.96
+5.34%
Orchestra BioMed Holdings Inc.
Normalized Baseline0.00%
Alpha Spread Margin OBIO LEADS
-50.17%
OBIO outperforming by 50.17%
AKANOBIO
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AKAN OBIO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | AKAN Price | AKAN Gain (%) | OBIO Price | OBIO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $2.68 | -44.83% | $5.96 | +5.34% | -50.17% |
| Sep 14, 2026 | $2.79 | -42.59% | $5.90 | +4.24% | -46.83% |
| Sep 11, 2026 | $3.07 | -36.83% | $6.12 | +8.13% | -44.96% |
| Sep 10, 2026 | $3.00 | -38.27% | $5.81 | +2.65% | -40.92% |
| Sep 09, 2026 | $3.25 | -33.13% | $5.45 | -3.71% | -29.42% |
| Sep 08, 2026 | $3.28 | -32.51% | $5.43 | -4.06% | -28.45% |
| Sep 04, 2026 | $3.35 | -31.07% | $5.08 | -10.25% | -20.82% |
| Sep 03, 2026 | $3.67 | -24.49% | $4.74 | -16.25% | -8.24% |
| Sep 02, 2026 | $3.74 | -23.05% | $4.95 | -12.54% | -10.51% |
| Sep 01, 2026 | $3.70 | -23.87% | $4.90 | -13.43% | -10.44% |
| Aug 31, 2026 | $4.08 | -16.15% | $5.04 | -10.95% | -5.20% |
| Aug 28, 2026 | $3.89 | -19.96% | $5.19 | -8.39% | -11.57% |
| Aug 27, 2026 | $4.23 | -12.96% | $5.11 | -9.72% | -3.24% |
| Aug 26, 2026 | $4.24 | -12.76% | $5.26 | -7.07% | -5.69% |
| Aug 25, 2026 | $4.95 | +1.85% | $5.36 | -5.30% | +7.15% |
Page 1 of 2